论文部分内容阅读
Constitutive activation of the transcription factor nuclear factor-kB (NF-κB) plays an important role in oncogenesis and drug resistance of several types of human cancers.Inhibiting NF-κB pathways is therefore emerging as a promising approach to treat cancer.